Building One of the Fastest Growing CPG Companies in History | Peter Rahal of David Protein, Medici Brands & RXBAR

What It Covers

Peter Rahal, who sold RXBAR for $600M while retaining 90% ownership, details his failed attempt at investing, his three-year path back to founding David Protein, and how the company reached $300M in revenue within two years by acquiring a patented fat-replacement ingredient and building a decentralized multi-brand CPG platform called Medici Brands.

Key Questions Answered

• •Operator vs. Investor Mismatch: Founders with extreme execution instincts are structurally unsuited to investing because feedback loops stretch to five-plus years, versus the near-immediate loops of operating decisions. Rahal spent roughly 12 months realizing he was "handcuffed in the back seat" watching founders he'd funded move too slowly, having wrongly assumed all entrepreneurs shared his willingness to sacrifice everything to win.
• •Vertical Integration as Competitive Weapon: When David Protein represented 90%—then 150%—of supplier Apogee's available output of the patented fat-replacement ingredient EPG, Rahal negotiated a most-favored-nation supply agreement before acquiring the company outright for half equity, half cash. Competitors without supply agreements lost access entirely, triggering an antitrust lawsuit dismissed three times, and one displaced founder was recruited directly onto the David team.
• •Brand Identity Construction: Rahal spent six months defining David's brand around three values—intelligence, beauty, and discipline—anchored to Michelangelo's sculpture as a symbolic framework. Once that identity is fixed, every marketing decision becomes a mechanical exercise of repeatedly hammering the same points. He cites David Ogilvy's core principle: the best brands are old because they maintained a single consistent identity across decades without deviation.
• •Recruiting Former Founders as Operators: The highest-performing employees at David Protein are former founders, not experienced CPG executives. Rahal actively targets them by positioning the company as a platform where founders can execute their vision with existing infrastructure, supply chain, and capital—without fundraising friction. Corporate hires require deliberate "baptism" through structured onboarding to replace ingrained cover-your-ass behaviors with first-principles thinking.
• •Decentralized Business Unit Structure for Speed: Medici Brands operates as a holding entity with semi-autonomous business units—each running its own P&L, sales, marketing, supply chain, and finance—modeled loosely on the Medici family's role enabling Renaissance artists. Rahal maintains roughly 25 direct reports to stay close to problems and reduce hierarchical lag. Finance acts as referee between supply accuracy and sales growth, defining pricing frameworks and budget rules.
• •Capital Efficiency Over Valuation Maximization: Rahal seeded David with $2M of personal capital, raised $8M for working capital, then $85M specifically to finance the Apogee acquisition from Green Oaks and Valor Equity—deliberately avoiding an auction process. His reasoning: management meetings and diligence responses consume operating bandwidth, and early-stage enterprise value optimization is irrelevant if the business compounds correctly. He continues investing personal capital in every subsequent round.